Steigerwald; Robin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Steigerwald; Robin.The latest application filed is for "methods and compositions for inducing protective immunity against filovirus infection".

Company Profile

14.25.32

Steigerwald; Robin - Munich DE
Steigerwald; Robin - Munchen DE
Steigerwald, Robin - Muenchen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding filovirus immunogens Grant 11,338,030 - Volkmann , et al. May 24, 2	2022-05-24
Methods And Compositions For Inducing Protective Immunity Against Filovirus Infection App 20220088170 - VOLKMANN; Ariane ; et al.	2022-03-24
Stable recombinant MVA vectors comprising modified RSV genes with reduced intramolecular recombinatorial activity Grant 11,225,673 - Steigerwald January 18, 2	2022-01-18
Recombinant Modified Vaccinia Virus Ankara (MVA) Foot and Mouth Disease Virus (FMDV) Vaccine App 20210393766 - Steigerwald; Robin ; et al.	2021-12-23
Methods and compositions for inducing protective immunity against filovirus infection Grant 11,173,201 - Volkmann , et al. November 16, 2	2021-11-16
Recombinant modified vaccinia virus Ankara (MVA) foot and mouth disease virus (FMDV) vaccine Grant 11,103,570 - Steigerwald , et al. August 31, 2	2021-08-31
Recombinant Modified Vaccinia Virus Ankara (MVA) Equine Encephalitis Virus Vaccine App 20210205439 - Steigerwald; Robin ; et al.	2021-07-08
Recombinant Modified Vaccinia Virus Ankara (MVA) Respiratory Syncytial Virus (RSV) Vaccine App 20210196814 - Cheminay; Cedric ; et al.	2021-07-01
PR13.5 promoter for robust T-cell and antibody responses Grant 11,028,130 - Steigerwald , et al. June 8, 2	2021-06-08
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine Grant 10,946,089 - Cheminay , et al. March 16, 2	2021-03-16
Methods and compositions for inducing protective immunity against a marburg virus infection Grant 10,925,956 - Callendret , et al. February 23, 2	2021-02-23
Recombinant modified vaccinia virus Ankara (MVA) equine encephalitis virus vaccine Grant 10,881,725 - Steigerwald , et al. January 5, 2	2021-01-05
Recombinant Modified Vaccinia Virus Ankara (MVA) Filovirus Vaccine App 20200268872 - Volkmann; Ariane ; et al.	2020-08-27
Recombinant Modified Vaccinia Virus Ankara (MVA) Respiratory Syncytial Virus (RSV) Vaccine App 20200171142 - Cheminay; Cedric ; et al.	2020-06-04
Use of oil and water emulsions for increasing B cell responses with modified Vaccinia Ankara virus Grant 10,653,766 - Cheminay , et al.	2020-05-19
Recombinant modified vaccinia virus Ankara (MVA) multivalent filovirus immunogenic compositions and methods of use Grant 10,576,141 - Volkmann , et al.	2020-03-03
Methods and compositions for inducing protective immunity against filovirus infection Grant 10,561,721 - Volkmann , et al. Feb	2020-02-18
Methods and compositions for enhancing immune responses Grant 10,561,722 - Volkmann , et al. Feb	2020-02-18
Methods And Compositions For Inducing Protective Immunity Against Filovirus Infection App 20200038500 - VOLKMANN; Ariane ; et al.	2020-02-06
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine Grant 10,532,094 - Cheminay , et al. Ja	2020-01-14
Methods And Compositions For Inducing Protective Immunity Against A Marburg Virus Infection App 20190224301 - CALLENDRET; Benoit Christophe Stephan ; et al.	2019-07-25
Recombinant Modified Vaccinia Virus Ankara (mva) Respiratory Syncytial Virus (rsv) Vaccine App 20190117764 - Cheminay; Cedric ; et al.	2019-04-25
Vector Comprising Multiple Homologous Nucleotide Sequences App 20190055582 - Steigerwald; Robin	2019-02-21
Recombinant Modified Vaccinia Virus Ankara (mva) Equine Encephalitis Virus Vaccine App 20190038739 - Steigerwald; Robin ; et al.	2019-02-07
Recombinant modified vaccinia virus Ankara (MVA) Respiratory Syncytial Virus (RSV) vaccine Grant 10,124,058 - Cheminay , et al. November 13, 2	2018-11-13
Poxviral vectors for low antibody response after a first priming immunization Grant 10,111,946 - Steigerwald , et al. October 30, 2	2018-10-30
Vector comprising multiple homologous nucleotide sequences Grant 10,072,274 - Steigerwald September 11, 2	2018-09-11
Recombinant Modified Vaccinia Virus Ankara (mva) Foot And Mouth Disease Virus (fmdv) Vaccine App 20180185466 - Steigerwald; Robin ; et al.	2018-07-05
Pr13.5 Promoter For Robust T-cell And Antibody Responses App 20180111966 - Steigerwald; Robin ; et al.	2018-04-26
Methods And Compositions For Enhancing Immune Responses App 20170340721 - VOLKMANN; Ariane ; et al.	2017-11-30
Pr13.5 promoter for robust T-cell and antibody responses Grant 9,828,414 - Steigerwald , et al. November 28, 2	2017-11-28
Recombinant Modified Vaccinia Virus Ankara (mva) Respiratory Syncytial Virus (rsv) Vaccine App 20170326228 - Cheminay; Cedric ; et al.	2017-11-16
Recombinant Modified Vaccinia Virus Ankara (mva) Filovirus Vaccine App 20170304427 - Volkmann; Ariane ; et al.	2017-10-26
Methods And Compositions For Inducing Protective Immunity Against Filovirus Infection App 20170290904 - VOLKMANN; Ariane ; et al.	2017-10-12
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine Grant 9,717,787 - Cheminay , et al. August 1, 2	2017-08-01
Vector Comprising Multiple Homologous Nucleotide Sequences App 20170211098 - STEIGERWALD; Robin	2017-07-27
Use Of Oil And Water Emulsions For Increasing B Cell Responses With Modified Vaccinia Ankara Virus App 20170128561 - Cheminay; Cedric ; et al.	2017-05-11
Recombinant Poxvirus Vector Comprising Tetanus Toxin Fragment C App 20170081642 - Chaplin; Paul ; et al.	2017-03-23
Recombinant Modified Vaccinia Virus Ankara (mva) Respiratory Syncytial Virus (rsv) Vaccine App 20170043008 - Cheminay; Cedric ; et al.	2017-02-16
Vector comprising multiple homologous nucleotide sequences Grant 9,540,660 - Steigerwald January 10, 2	2017-01-10
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine Grant 9,480,738 - Cheminay , et al. November 1, 2	2016-11-01
Recombinant poxvirus vector comprising tetanus toxin fragment C Grant 9,463,238 - Chaplin , et al. October 11, 2	2016-10-11
Vector Comprising Multiple Homologous Nucleotide Sequences App 20160017369 - STEIGERWALD; Robin	2016-01-21
Pr13.5 Promoter For Robust T-cell And Antibody Responses App 20150299267 - Steigerwald; Robin ; et al.	2015-10-22
Recombinant Modified Vaccinia Virus Ankara (mva) Respiratory Syncytial Virus (rsv) Vaccine App 20150209421 - Cheminay; Cedric ; et al.	2015-07-30
Poxviral Vectors For Low Antibody Response After A First Priming Immunization App 20150174238 - Steigerwald; Robin ; et al.	2015-06-25
Vector comprising multiple homologous nucleotide sequences Grant 8,999,637 - Steigerwald April 7, 2	2015-04-07
Promoters For Recombinant Viral Expression App 20140342403 - STEIGERWALD; Robin ; et al.	2014-11-20
Recombinant Poxvirus Vector Comprising Tetanus Toxin Fragment C App 20140322265 - Chaplin; Paul ; et al.	2014-10-30
Promoters for recombinant viral expression Grant 8,772,023 - Steigerwald , et al. July 8, 2	2014-07-08
Recombinant Modified Vaccinia Virus Ankara Influenza Vaccine App 20130183335 - Weigl; Josef ; et al.	2013-07-18
Promoters For Recombinant Viral Expression App 20120121617 - Steigerwald; Robin ; et al.	2012-05-17
Vector Comprising Multiple Homologous Nucleotide Sequences App 20110236976 - Steigerwald; Robin	2011-09-29
Method for increasing the solubility, expression rate and the acitivity of proteins during recombinant production App 20040248238 - Watzele, Manfred ; et al.	2004-12-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.